Bristol-Myers Squibb Company
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
Last updated:
Abstract:
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
14 Jun 2017
Issue date:
17 Dec 2019